Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
HdwkDpyaHHt0FuS2
